Nature computational science · 2022
Unconstrained generation of synthetic antibody-antigen structures to guide machine learning methodology for antibody specificity prediction.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Robert Philippe A, Akbar Rahmad, Frank Robert, Pavlović Milena, Widrich Michael, Snapkov Igor, Slabodkin Andrei, Chernigovskaya Maria, Scheffer Lonneke, Smorodina Eva, Rawat Puneet, Mehta Brij Bhushan, Vu Mai Ha, Mathisen Ingvild Frøberg, Prósz Aurél, Abram Krzysztof, Olar Alex, Miho Enkelejda, Haug Dag Trygve Tryslew, Lund-Johansen Fridtjof, Hochreiter Sepp, Haff Ingrid Hobæk, Klambauer Günter, Sandve Geir Kjetil, Greiff Victor
Аннотация
Machine learning (ML) is a key technology for accurate prediction of antibody-antigen binding. Two orthogonal problems hinder the application of ML to antibody-specificity prediction and the benchmarking thereof: the lack of a unified ML formalization of immunological antibody-specificity prediction problems and the unavailability of large-scale synthetic datasets to benchmark real-world relevant ML methods and dataset design. Here we developed the Absolut! software suite that enables parameter-based unconstrained generation of synthetic lattice-based three-dimensional antibody-antigen-binding structures with ground-truth access to conformational paratope, epitope and affinity. We formalized common immunological antibody-specificity prediction problems as ML tasks and confirmed that for both sequence- and structure-based tasks, accuracy-based rankings of ML methods trained on experimental data hold for ML methods trained on Absolut!-generated data. The Absolut! framework has the potential to enable real-world relevant development and benchmarking of ML strategies for biotherapeutics design.